Download Files:
Products Details
Product Description
– ML3403 is a potent p38 MAPK inhibitor with an IC50 of 0.38 μM[1].
Web ID
– HY-110103
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C23H21FN4S
References
– [1]Kammerer B, et al. Pharmacokinetics of ML3403 ({4-[5-(4-fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-type p38 mitogen-activated protein kinase inhibitor. Drug Metab Dispos. 2007 Jun;35(6):875-83.
CAS Number
– 549505-65-9
Molecular Weight
– 404.50
SMILES
– CC(NC1=NC=CC(C2=C(C3=CC=C(F)C=C3)N=C(SC)N2)=C1)C4=CC=CC=C4
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– p38 MAPK
Pathway
– MAPK/ERK Pathway
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
